3-(3,4-Dimethoxyphenyl)-5-(2,4-dimethoxyphenyl)-1H-pyrrolo-[2,3-b]pyridine

ID: ALA3102946

PubChem CID: 72792757

Max Phase: Preclinical

Molecular Formula: C23H22N2O4

Molecular Weight: 390.44

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)c(OC)c1

Standard InChI:  InChI=1S/C23H22N2O4/c1-26-16-6-7-17(21(11-16)28-3)15-9-18-19(13-25-23(18)24-12-15)14-5-8-20(27-2)22(10-14)29-4/h5-13H,1-4H3,(H,24,25)

Standard InChI Key:  RYIPFFFNGKQOMG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   32.6150  -22.8081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6139  -23.6355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3286  -24.0484    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.3268  -22.3953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9004  -22.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0423  -22.8045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0425  -23.6356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8330  -23.8922    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3213  -23.2196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8326  -22.5476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2205  -21.8203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0457  -21.7954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4340  -21.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9977  -20.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1689  -20.3975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7844  -21.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9037  -21.5699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1900  -21.1576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4746  -21.5703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4775  -22.3996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1917  -22.8081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7595  -21.1589    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.7582  -20.3340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3851  -19.6387    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.2095  -19.6099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1949  -23.6331    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.4819  -24.0483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2585  -21.0410    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.6944  -21.7414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  7  2  0
  6  4  2  0
  4  1  1  0
  1  5  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  6  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  5 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  5  1  0
 19 22  1  0
 22 23  1  0
 14 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 13 28  1  0
 28 29  1  0
M  END

Associated Targets(Human)

KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dyrk1a Dual specificity tyrosine-phosphorylation-regulated kinase 1A (1629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.44Molecular Weight (Monoisotopic): 390.1580AlogP: 4.93#Rotatable Bonds: 6
Polar Surface Area: 65.60Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.85CX LogP: 3.89CX LogD: 3.89
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -0.23

References

1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH..  (2013)  Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.,  56  (23): [PMID:24188002] [10.1021/jm401049v]
2. Lee S, Lee H, Kim J, Lee S, Kim SJ, Choi BS, Hong SS, Hong S..  (2014)  Development and biological evaluation of potent and selective c-KIT(D816V) inhibitors.,  57  (15): [PMID:25004409] [10.1021/jm500413g]

Source